(2S,3R)-2-amino-3-[(4,4-difluorocyclohexyl)methoxy]-1-[4-(trifluoromethyl)piperidin-1-yl]butan-1-one
C17H27F5N2O2 — CID 164604915
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2S,3R)-2-amino-3-[(4,4-difluorocyclohexyl)methoxy]-1-[4-(trifluoromethyl)piperidin-1-yl]butan-1-one
(2S,3R)-2-amino-3-[(4,4-difluorocyclohexyl)methoxy]-1-[4-(trifluoromethyl)piperidin-1-yl]butan-1-one (PubChem CID 164604915) has the molecular formula C17H27F5N2O2 and a molecular weight of 386.41 g/mol. Its IUPAC name is (2S,3R)-2-amino-3-[(4,4-difluorocyclohexyl)methoxy]-1-[4-(trifluoromethyl)piperidin-1-yl]butan-1-one.
Molecular Properties
| Compound Name | (2S,3R)-2-amino-3-[(4,4-difluorocyclohexyl)methoxy]-1-[4-(trifluoromethyl)piperidin-1-yl]butan-1-one |
|---|---|
| PubChem CID | 164604915 |
| Molecular Formula | C17H27F5N2O2 |
| Molecular Weight | 386.41 g/mol |
| Exact Mass | 386.20 |
| IUPAC Name | (2S,3R)-2-amino-3-[(4,4-difluorocyclohexyl)methoxy]-1-[4-(trifluoromethyl)piperidin-1-yl]butan-1-one |
| SMILES | C[C@@H](OCC1CCC(F)(F)CC1)[C@H](N)C(=O)N1CCC(C(F)(F)F)CC1 |
| InChI | InChI=1S/C17H27F5N2O2/c1-11(26-10-12-2-6-16(18,19)7-3-12)14(23)15(25)24-8-4-13(5-9-24)17(20,21)22/h11-14H,2-10,23H2,1H3/t11-,14+/m1/s1 |
| InChIKey | QGMKCYPERDJGKS-RISCZKNCSA-N |
| XLogP | 3.35 |
| TPSA | 55.56 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 26 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 386.41 |
| LogP ≤ 5 | 3.35 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 3 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 164604915 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.